Lexicon Pharmaceuticals, Inc. (LXRX) stock forecast and price target
Price $1.79 · data as of November 13, 2026
12-month price target
Average target$4.51
Upside / downside+152.2%
Analysts6
ConsensusBuy
Low $1.69Average $4.51High $8.00
Gold marker: average target · white marker: today’s price ($1.79)
Analyst ratings
Strong buy 1Buy 3Hold 2Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.16 | −13.5% | $37M |
| Next fiscal year ends December 31, 2027 | $-0.21 | −34.0% | $18M |
| Next quarter ends December 31, 2026 | $-0.05 | −35.5% | $4M |
| Quarter after ends March 31, 2027 | $-0.06 | +0.0% | $603330 |
Consensus of the analysts covering Lexicon Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Lexicon Pharmaceuticals stock price target?
The average 12-month target from 6 analysts is $4.51, 152.2% above the current price of $1.79 Targets range from $1.69 to $8.00.
Is Lexicon Pharmaceuticals a buy according to analysts?
The consensus rating is “Buy” (1 strong buy, 3 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Lexicon Pharmaceuticals expected to earn?
Analysts expect EPS of $-0.16 for the fiscal year ending December 31, 2026 and $-0.21 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.